Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Only 3 Minutes Needed for Skin Swab Test to Detect Parkinson Disease
09/20/2022
Jolynn Tumolo
A noninvasive sampling technique can readily distinguish people with Parkinson disease from matched controls in less than 3 minutes, according to a study published online in the Journal of the American Chemical Society. “We are...
A noninvasive sampling technique can readily distinguish people with Parkinson disease from matched controls in less than 3 minutes, according to a study published online in the Journal of the American Chemical Society. “We are...
A noninvasive sampling technique...
09/20/2022
Neurology
News
Extended-Release Viloxazine and Caffeine Combined Together May Raise Insomnia Risk
09/20/2022
Jolynn Tumolo
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with...
09/20/2022
Psych Congress Network
News
FDA Clears Neuromodulation System for Patients With MDD
09/19/2022
Jolynn Tumolo
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug...
09/19/2022
Psych Congress Network
News
Added Brexpiprazole Improves Life Engagement in Adults With Major Depression
09/18/2022
Jolynn Tumolo
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was...
09/18/2022
Psych Congress Network
News
Zuranolone Eases MDD for Majority of Study Participants, Interim Analysis Shows
09/18/2022
Jolynn Tumolo
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase...
09/18/2022
Psych Congress Network
News
Goal Management Training for Patients With Schizophrenia, Psychosis Risk
09/16/2022
Jolynn Tumolo
For patients diagnosed with schizophrenia and psychosis risk syndromes, goal management training improved a number of outcomes, including executive function.
For patients diagnosed with schizophrenia and psychosis risk syndromes, goal management training improved a number of outcomes, including executive function.
For patients diagnosed with...
09/16/2022
Veterans Health Today
News
Adherence to Treatment Poor in 4 of 10 Adults With Eosinophilic Esophagitis
09/16/2022
Jolynn Tumolo
Age, duration of disease, symptom severity, and beliefs about the necessity of treatment affected patients' odds of poor treatment adherence.
Age, duration of disease, symptom severity, and beliefs about the necessity of treatment affected patients' odds of poor treatment adherence.
Age, duration of disease,...
09/16/2022
First Report Managed Care
News
Oral JAK Inhibitors Well Tolerated in Patients With Alopecia Areata
09/16/2022
Jolynn Tumolo
Findings showed JAK inhibitors were efficacious with oral administration, but topical or sublingual administration lacked efficacy.
Findings showed JAK inhibitors were efficacious with oral administration, but topical or sublingual administration lacked efficacy.
Findings showed JAK inhibitors...
09/16/2022
First Report Managed Care
News
Antihistamine Recalled
09/15/2022
Jolynn Tumolo
More than a half-million cups of an over-the-counter antihistamine are being recalled due to inadequately controlled manufacturing processes.
More than a half-million cups of an over-the-counter antihistamine are being recalled due to inadequately controlled manufacturing processes.
More than a half-million cups of...
09/15/2022
Pharmacy Learning Network
News
Pain Reliever Recalled
09/15/2022
Jolynn Tumolo
A Class II recall has been issued for numerous lots of acetaminophen oral solution.
A Class II recall has been issued for numerous lots of acetaminophen oral solution.
A Class II recall has been...
09/15/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use